Slawson R G, Poka A, Bathon H, Salazar O M, Bromback R J, Burgess A R
Department of Radiation Oncology, University of Maryland Hospital, Baltimore 21201.
Int J Radiat Oncol Biol Phys. 1989 Sep;17(3):669-72. doi: 10.1016/0360-3016(89)90122-3.
Heterotopic ossification (HO) with subsequent pain and limitation of motion of the lower extremity is a common and significant problem for patients who suffer traumatic acetabular fracture (TAF). The incidence of heterotopic ossification is markedly increased for patients requiring surgical repair depending on the degree of trauma and the type of surgical repair necessary. Radiation therapy (RT) has proven to be the most effective surgical adjunct for the prevention of heterotopic ossification in patients undergoing total hip replacement (THR), but has not been reported in patients with traumatic fracture and repair. This report details an experience with patients treated at a Shock Trauma Center with extensile repair and immediate (within 48 hr) post-operative radiation therapy given as 5 daily fractions of 2 Gy in 5 to 7 days to a total dose of 10 Gy using megavoltage radiation therapy. A total of 30 consecutive patients (RT group) have been treated at our institution since June 1985. The last 20 patients treated with surgery only (non-RT group) prior to initiation of this study were used as a control group. Heterotopic ossification was seen to some degree in 50% of all radiation therapy patients, but was severe in only three of 30 (10%) of cases [three (10%) had Brooker III HO and no patients had ankylosis (Brooker IV HO)]. In contrast, some degree of heterotopic ossification was seen in 90% of the non-radiation therapy patients, and was severe in 10 of 20 (50%) of patients [seven (35%) had Brooker III HO whereas three (15%) had ankylosis (Brooker IV)]. This difference is significant for both total incidence and incidence of severe cases (p less than 0.01). This reduction in heterotopic ossification incidence approaches the magnitude reported for high-risk patients with total hip replacement. Even though the incidence of severe heterotopic ossification after radiation therapy for total hip replacement is approximately 5% and for traumatic acetabular fracture patients it is double (10%), the actual incidence of heterotopic ossification without radiation therapy is different in the two conditions. For total hip replacement, the incidence is about 30% and for traumatic acetabular fracture it is 50%. Radiation therapy has again proven itself to be an excellent surgical adjunct to prevent heterotopic ossification, this time in traumatic acetabular fracture patients.
异位骨化(HO)以及随后出现的下肢疼痛和活动受限,是创伤性髋臼骨折(TAF)患者常见且严重的问题。根据创伤程度和所需手术修复类型,需要手术修复的患者异位骨化的发生率显著增加。放射治疗(RT)已被证明是预防全髋关节置换(THR)患者异位骨化最有效的手术辅助手段,但在创伤性骨折及修复患者中尚未见报道。本报告详细介绍了在一家创伤中心对患者的治疗经验,这些患者接受了扩展性修复,并在术后立即(48小时内)进行放射治疗,采用兆伏级放射治疗,在5至7天内每天分5次给予2 Gy,总剂量为10 Gy。自1985年6月以来,共有30例连续患者(放疗组)在我们机构接受治疗。在本研究开始前,仅接受手术治疗的最后20例患者(非放疗组)用作对照组。在所有接受放射治疗的患者中,50%出现了一定程度的异位骨化,但在30例患者中只有3例(10%)严重[3例(10%)为布鲁克三级HO,无患者发生关节强直(布鲁克四级HO)]。相比之下,90%的非放射治疗患者出现了一定程度的异位骨化,20例患者中有10例(50%)严重[7例(35%)为布鲁克三级HO,而3例(15%)发生关节强直(布鲁克四级)]。这种差异在总发生率和严重病例发生率方面均具有统计学意义(p小于0.01)。异位骨化发生率的降低幅度接近高危全髋关节置换患者的报道水平。尽管全髋关节置换术后放射治疗后严重异位骨化的发生率约为5%,创伤性髋臼骨折患者的发生率是其两倍(10%),但两种情况下未进行放射治疗时异位骨化的实际发生率有所不同。全髋关节置换时发生率约为30%,创伤性髋臼骨折时为50%。放射治疗再次证明自身是预防异位骨化的优秀手术辅助手段,此次是在创伤性髋臼骨折患者中。